Andrew Zeitlin
26Patents
16h-index
27Co-inventors
81Inventor score
Filing activity: Jun 22, 1989 → Nov 18, 2014
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5837284A | Delivery of multiple doses of medications | Human Necessities | 367 | Expired |
| US5908850A | Method of treating attention deficit disorders with d-threo methylphenidate | Human Necessities | 139 | Expired |
| US6355656B1 | Phenidate drug formulations having diminished abuse potential | Chemistry; Metallurgy | 105 | Expired |
| US6528530B2 | Phenidate drug formulations having diminished abuse potential | Chemistry; Metallurgy | 86 | Expired |
| US5300437A | Enantiomeric enrichment and stereoselective synthesis of chiral amines | Chemistry; Metallurgy | 78 | Expired |
| US6635284B2 | Delivery of multiple doses of medications | Human Necessities | 77 | Expired |
| US5169780A | Enantiomeric enrichment and stereoselective synthesis of chiral amines | Chemistry; Metallurgy | 71 | Expired |
| US4950606A | Enantiomeric enrichment and stereoselective synthesis of chiral amines | Chemistry; Metallurgy | 68 | Expired |
| US7700090B2 | Co-culture of placental stem cells and stem cells from a second source | Chemistry; Metallurgy | 51 | Active |
| US7431944B2 | Delivery of multiple doses of medications | Human Necessities | 43 | Expired |
| US5346828A | Stereoisomeric enrichment of 2-amino-3-hydroxy-3-phenylpropionic acids using d-threonine aldolase | Emerging Cross-Sectional Technologies | 37 | Expired |
| US6255325A | Chronic, bolus administration of D-threo methylphenidate | Chemistry; Metallurgy | 33 | Expired |
| US7115631B2 | Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate | Chemistry; Metallurgy | 26 | Expired |
| US8263065B2 | Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells | Human Necessities | 23 | Active |
| US5733756A | Lactams and processes for stereoselective enrichment of lactams, amides, and esters | Chemistry; Metallurgy | 22 | Expired |
| US8926964B2 | Methods of generating natural killer cells | Emerging Cross-Sectional Technologies | 17 | Active |
| US6602887B2 | Chronic, bolus administration of D-threo methylphenidate | Chemistry; Metallurgy | 16 | Expired |
| US7435726B2 | Compositions and methods for the treatment of cancer | Human Necessities | 10 | Expired |
| US5922736A | Chronic, bolus administration of D-threo methylphenidate | Chemistry; Metallurgy | 9 | Expired |
| US8455250B2 | Co-culture of placental stem cells and stem cells from a second source | Chemistry; Metallurgy | 8 | Active |
| US5985933A | Methods for treating central and peripheral nerve pain | Chemistry; Metallurgy | 7 | Expired |
| US9464274B2 | Methods of generating natural killer cells | Emerging Cross-Sectional Technologies | 7 | Active |
| US7479499B2 | Methods of using thalidomide in combination with irinotecan | Human Necessities | 6 | Active |
| US6914067B2 | Compositions and methods for the treatment of colorectal cancer | Human Necessities | 4 | Expired |
| US9216200B2 | Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells | Human Necessities | 3 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.